Ignite Creation Date:
2026-03-26 @ 3:20 PM
Ignite Modification Date:
2026-03-31 @ 4:32 PM
Study NCT ID:
NCT07322718
Status:
RECRUITING
Last Update Posted:
2026-01-23
First Post:
2025-12-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Efficacy Study of RXIM002 in Severe, Relapsed or Refractory Autoimmune Diseases
Sponsor:
Ruijin Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-12-24
Start Date Type:
ACTUAL
Primary Completion Date:
2027-12-19
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-03-19
Completion Date Type:
ESTIMATED
First Submit Date:
2025-12-07
First Submit QC Date:
None
Study First Post Date:
2026-01-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2026-01-21
Last Update Post Date:
2026-01-23
Last Update Post Date Type:
ACTUAL